Abstract:
PURPOSE: A composition containing Hopea odorata Roxb. extract with anti-inflammation is provided to control macrophage function and to prevent and treat acure/chronic inflammation immunity and autoimmune response. CONSTITUTION: A pharmaceutical composition contains Hopea odorata Roxb. extract as an active ingredient. The extract is isolated using methanol, ethanol, or water. The extract is prepared by isolating Hopea odorata Roxb. with ethanol, suspending with water, and fractioning with n-hexane, ethyl acetate, and n-butanol. The extract is prepared in the form of a carrier, excipient, or diluent. The extract suppresses NO generation and pro-inflammatory cytokines(IL-6, GM-CSF, IL-1β and TNF-alpha). A neutraceutical food contains the hot water extract of Hopea odorata Roxb. as an active ingredient.
Abstract:
본 발명은 더덕 추출물 또는 더덕 사포닌을 유효성분으로 포함하는 비만세포로부터 히스타민의 분비를 억제하는 효과를 갖는 조성물에 관한 것이다. 본 발명의 조성물과 이를 포함하는 제품은 소양증을 비롯하여 발적, 화끈거리는 열감, 두드러기, 재채기, 맑은 콧물, 코막힘, 객담증가, 흉부압박감, 호흡곤란, 순환기계의 빈맥, 저혈압, 전신 무기력증, 어지러움증과 같은 히스타민의 필요이상의 분비로 인하여 발생되는 질병이나 증상의 예방 또는 치료용도로 사용될 수 있다. 본 발명의 조성물 및 이를 함유하는 제품은 사람뿐만 아니라 동물에도 적용할 수 있다. 더덕, 사포닌, 소양증, 비만세포, 탈과립, 히스타민
Abstract:
PURPOSE: A Dryopteris Crassirhizoma extract with activity of anti-inflammation and immunity regulation is provided to suppress expression and generation of TNF-alpha and prostaglandin. CONSTITUTION: A composition for anti-inflammation and immunity regulation contains Dryopteris Crassirhizoma extract as an active ingredient. The Dryopteris Crassirhizoma extract suppresses NO generation. The composition contains 12.5 ug/ml or more of Dryopteris Crassirhizoma extract as an active ingredient.
Abstract:
PURPOSE: A life medical treatment auxiliary system for monitoring a biological signal is provided to measure the state of a person in outside by enabling a monitored person to directly confirmed measured data about the biological signal. CONSTITUTION: Sensors(12, 14, 16) measures the body state of a monitored person. A local data management unit receives measured data from the sensors. The local data management unit determines the state of the monitored person based on the measured data. A monitoring server(60) stores the measured data which receives measuring view point information in a DB(Data Base).
Abstract:
PURPOSE: A composition containing Codonopis lanceolata extract or Codonopis lanceolata saponin is provided to prevent hair loss or to promote hair growth. CONSTITUTION: A composition for promoting hair growth contains Codonopis lanceolata extract as an active ingredient. The Codonopis lanceolata extract is saponin fraction of Codonopis lanceolata. The composition contains Codonopis lanceolata saponin as an active ingredient. An external use skin formulation for hair growth containing the composition is used in the form of scalp treatment, soap, hair tonic, shampoo, rinse, hair pack, lotion conditioner, hair oil, cream, soild formulation, dispersing agent, liposome or ointment.
Abstract:
본 발명은 더덕 추출물 또는 더덕의 사포닌을 유효성분으로 포함하는 발모 또는 양모 촉진용 조성물 및 이를 포함하는 피부외용제 또는 기능성 식품에 관한 것이다. 본 발명은 또한 더덕 추출물 또는 더덕의 사포닌을 유효성분으로 포함하는 조성물을 사용하여 발모 또는 양모를 촉진하는 방법을 제공한다. 본 발명의 조성물 및 이를 함유하는 제품은 사람 뿐만 아니라 애완동물이나, 털을 채취하거나 모피를 이용하는 동물에 적용할 수 있다. 더덕, 사포닌, 발모, 양모
Abstract:
PURPOSE: A resveratrol derivative compound having activities of anti-inflammation and immune modulation is provided to reduce NO generation and suppress anti-inflammation with low cytotoxicity. CONSTITUTION: A composition for preventing or treating inflammatory diseases contains a compound of chemical formula 1 as an active ingredient. In chemical formula 1, OH is substituted with ortho, meta or para of phenyl ring; either m or n is not 0 and independently 0, 1 or 2. A functional health food for preventing or treating inflammatory diseases contains resveratrol derivative of chemical formula 1 and sitologically acceptable food additive.
Abstract:
PURPOSE: A composition containing Codonopis lanceolata extract or Codonopis lanceolata saponin is provided to prevent or treat diseases or symptom caused by excessive histamine secretion. CONSTITUTION: A composition for suppressing histamine secretion contains Codonopis lanceolata or Codonopis lanceolata saponin as an active ingredient. A composition for preventin or treating disease or symptom caused by excessive histamine secretion contains Codonopis lanceolata or Codonopis lanceolata saponin as an active ingredient. The diseases or symptom caused by excessive histamine secretion is pruritus, rhinorrhea, nasal obstruction, idle talk increase, chest pressure feeling, respiratory distress, circulating machine, and hypotension. A pharmaceutical composition for preventing or treating pruritus contains Codonopis lanceolata saponin as an active ingredient.